search
Back to results

Using 3D Imaging to Optimize Bifurcation Stenting

Primary Purpose

Coronary Artery Disease, Bifurcation Lesion

Status
Unknown status
Phase
Phase 4
Locations
International
Study Type
Interventional
Intervention
3D OFDI guidance arm
Angio guidance arm
Sponsored by
Increase Co., Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Coronary Artery Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patient is at least 18 years of age and signed Informed Consent
  2. Subject has coronary artery disease involving a bifurcation with objective evidence of ischemia including patients with chronic stable angina, silent ischemia and non-ST segment elevation acute coronary syndrome (NSTE-ACS)
  3. Subject is appropriate to be treated by PCI according to the local practice (operator's judgment or heart team decision)
  4. Patients' residence is in the area covered by the hospital
  5. Patients with angiographically significant stenosis (>50 % by visual assessment) in de novo, native, previously unstented bifurcation lesion(s) including left main lesion, which is in operator's opinion appropriate to be treated by PCI with a single stent strategy
  6. The size of main vessel matches available Ultimaster stent sizes (<4.0 mm, and 2.0 mm by visual assessment)
  7. The size of side branch is >2.0mm in diameter by visual assessment
  8. The sidebranch is treatable with a sidebranch fenestration and/or kissing balloon

Exclusion Criteria:

  1. Pregnancy
  2. Patients with ST elevation myocardial infarction
  3. Known intolerance to aspirin, clopidogrel, heparin, cobalt chromium, sirolimus, contrast material
  4. Known thrombocytopenia (platelet count< 100,000/mm3)
  5. Cardiogenic Shock
  6. Significant comorbidities precluding clinical follow-up (as judged by investigators)
  7. Major planned surgery that requires discontinuation of dual antiplatelet therapy
  8. History of stenting in the target bifurcation lesion
  9. Renal insufficiency (GFR/MDRD <45 ml/min), which precludes in operator's opinion contrast injection during repeat OFDI pullback
  10. Severely tortuous or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub-optimal optical frequency domain imaging (OFDI) or excessive risk of complication to place an OFDI catheter
  11. Target lesion reference vessel diameter (RVD) < 2.25 and > 4 mm
  12. Other: Patient is judged inappropriate by the attending physician

Sites / Locations

  • Fujita Health University
  • Erasmus University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

3D OFDI guidance arm

Angio guidance arm

Arm Description

Bifurcation percutaneous coronary intervention (PCI) optimized by online-3D OFDI during and after procedure

Bifurcation percutaneous coronary intervention (PCI) guided by angiography

Outcomes

Primary Outcome Measures

Percentage of malapposed struts
Percentage of malapposed struts assessed by OFDI in bifurcation segment of main vessel

Secondary Outcome Measures

Incidence of fulfilling optimal recrossing criteria on 3D-OFDI
Measured as a percentage
Incomplete stent apposition (ISA) area (mm²)
Minimum lumen area (mm²)
Mean lumen area (mm²)
Minimum stent area (mm²)
Mean stent area (mm²)
Mean protrusion area (mm²)
Maximum protrusion area (mm²)
Minimum flow area (mm²)
Mean flow area (mm²)

Full Information

First Posted
November 14, 2016
Last Updated
November 21, 2016
Sponsor
Increase Co., Ltd.
Collaborators
Fujita Health University, Erasmus Medical Center, Terumo Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT02972489
Brief Title
Using 3D Imaging to Optimize Bifurcation Stenting
Official Title
On-line 3-dimensional Optical Frequency Domain Imaging to Optimize Bifurcation Stenting Using UltiMaster Stent: OPTIMUM Study
Study Type
Interventional

2. Study Status

Record Verification Date
November 2016
Overall Recruitment Status
Unknown status
Study Start Date
January 2017 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
December 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Increase Co., Ltd.
Collaborators
Fujita Health University, Erasmus Medical Center, Terumo Corporation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary purpose of this study is to determine whether bifurcation stenting guided by on-line three-dimensional optical frequency domain imaging (3D-OFDI) is superior to that with angiographic guidance by measuring incomplete stent apposition (ISA) in the bifurcation segment.
Detailed Description
The recently developed optical frequency domain imaging (OFDI) can provide high quality resolution images of the coronary arteries. This new imaging system enhances the understanding of complex coronary lesions and the complex interaction between coronary devices and vessels by assembling/compiling 2-dimensional cross sections. This 3-dimensional reconstruction with strut segmentation becomes possible on-line in the TERUMO OFDI console with 3-dimensional imaging software, which enables stent enhancement and 3D reconstruction within one minute. This "real time" 3D OFDI will promote the utilisation of 3-dimensional assessment in the treatment of bifurcation lesions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease, Bifurcation Lesion

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
106 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
3D OFDI guidance arm
Arm Type
Experimental
Arm Description
Bifurcation percutaneous coronary intervention (PCI) optimized by online-3D OFDI during and after procedure
Arm Title
Angio guidance arm
Arm Type
Active Comparator
Arm Description
Bifurcation percutaneous coronary intervention (PCI) guided by angiography
Intervention Type
Device
Intervention Name(s)
3D OFDI guidance arm
Intervention Description
Subjects randomized to 3D-guidance arm will undergo optical frequency domain imaging (OFDI) assessment in the main vessel after re-wiring into the jailed side branch following stent implantation. If the position of the wire is not located in the optimal cell, further attempts to redirect the wire to the optimal cell will be performed, with subsequent OFDI acquisitions to confirm position in 2D and off-line 3D reconstruction. After procedure, OFDI is performed in the main branch.
Intervention Type
Device
Intervention Name(s)
Angio guidance arm
Intervention Description
In angiography-guidance group, wire recrossing into the side branch will be performed using conventional fluoroscopic/angiographic guidance. After finishing the procedure, OFDI is performed in the main branch but the results will be blinded to the operators.
Primary Outcome Measure Information:
Title
Percentage of malapposed struts
Description
Percentage of malapposed struts assessed by OFDI in bifurcation segment of main vessel
Time Frame
at time of bifurcation PCI surgery
Secondary Outcome Measure Information:
Title
Incidence of fulfilling optimal recrossing criteria on 3D-OFDI
Description
Measured as a percentage
Time Frame
at time of bifurcation PCI surgery
Title
Incomplete stent apposition (ISA) area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Minimum lumen area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Mean lumen area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Minimum stent area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Mean stent area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Mean protrusion area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Maximum protrusion area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Minimum flow area (mm²)
Time Frame
at time of bifurcation PCI surgery
Title
Mean flow area (mm²)
Time Frame
at time of bifurcation PCI surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is at least 18 years of age and signed Informed Consent Subject has coronary artery disease involving a bifurcation with objective evidence of ischemia including patients with chronic stable angina, silent ischemia and non-ST segment elevation acute coronary syndrome (NSTE-ACS) Subject is appropriate to be treated by PCI according to the local practice (operator's judgment or heart team decision) Patients' residence is in the area covered by the hospital Patients with angiographically significant stenosis (>50 % by visual assessment) in de novo, native, previously unstented bifurcation lesion(s) including left main lesion, which is in operator's opinion appropriate to be treated by PCI with a single stent strategy The size of main vessel matches available Ultimaster stent sizes (<4.0 mm, and 2.0 mm by visual assessment) The size of side branch is >2.0mm in diameter by visual assessment The sidebranch is treatable with a sidebranch fenestration and/or kissing balloon Exclusion Criteria: Pregnancy Patients with ST elevation myocardial infarction Known intolerance to aspirin, clopidogrel, heparin, cobalt chromium, sirolimus, contrast material Known thrombocytopenia (platelet count< 100,000/mm3) Cardiogenic Shock Significant comorbidities precluding clinical follow-up (as judged by investigators) Major planned surgery that requires discontinuation of dual antiplatelet therapy History of stenting in the target bifurcation lesion Renal insufficiency (GFR/MDRD <45 ml/min), which precludes in operator's opinion contrast injection during repeat OFDI pullback Severely tortuous or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub-optimal optical frequency domain imaging (OFDI) or excessive risk of complication to place an OFDI catheter Target lesion reference vessel diameter (RVD) < 2.25 and > 4 mm Other: Patient is judged inappropriate by the attending physician
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yoshinobu Onuma
Phone
(011)+31-10-704-0704
Email
yoshinobuonuma@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yoshinobu Onuma
Organizational Affiliation
Fujita Health University/Erasmus University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fujita Health University
City
Toyoake
State/Province
Aichi Prefecture
ZIP/Postal Code
470-1192
Country
Japan
Facility Name
Erasmus University Medical Center
City
Rotterdam
State/Province
South Holland
ZIP/Postal Code
3015 CE
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
25256198
Citation
Lassen JF, Holm NR, Stankovic G, Lefevre T, Chieffo A, Hildick-Smith D, Pan M, Darremont O, Albiero R, Ferenc M, Louvard Y. Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. EuroIntervention. 2014 Sep;10(5):545-60. doi: 10.4244/EIJV10I5A97.
Results Reference
background
PubMed Identifier
23714592
Citation
Foin N, Torii R, Alegria E, Sen S, Petraco R, Nijjer S, Ghione M, Davies JE, Di Mario C. Location of side branch access critically affects results in bifurcation stenting: Insights from bench modeling and computational flow simulation. Int J Cardiol. 2013 Oct 9;168(4):3623-8. doi: 10.1016/j.ijcard.2013.05.036. Epub 2013 May 25.
Results Reference
background
PubMed Identifier
22581489
Citation
Alegria-Barrero E, Foin N, Chan PH, Syrseloudis D, Lindsay AC, Dimopolous K, Alonso-Gonzalez R, Viceconte N, De Silva R, Di Mario C. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters. EuroIntervention. 2012 Jun 20;8(2):205-13. doi: 10.4244/EIJV8I2A34.
Results Reference
background
PubMed Identifier
22334321
Citation
Okamura T, Onuma Y, Garcia-Garcia HM, Bruining N, Serruys PW. High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis. EuroIntervention. 2012 Feb;7(10):1216-26. doi: 10.4244/EIJV7I10A194.
Results Reference
background
PubMed Identifier
24531393
Citation
Okamura T, Onuma Y, Yamada J, Iqbal J, Tateishi H, Nao T, Oda T, Maeda T, Nakamura T, Miura T, Yano M, Serruys PW. 3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting. EuroIntervention. 2014 Dec;10(8):907-15. doi: 10.4244/EIJV10I8A157.
Results Reference
background
PubMed Identifier
33272034
Citation
Onuma Y, Kogame N, Sotomi Y, Miyazaki Y, Asano T, Takahashi K, Kawashima H, Ono M, Katagiri Y, Kyono H, Nakatani S, Muramatsu T, Sharif F, Ozaki Y, Serruys PW, Okamura T; OPTIMUM Investigators. A Randomized Trial Evaluating Online 3-Dimensional Optical Frequency Domain Imaging-Guided Percutaneous Coronary Intervention in Bifurcation Lesions. Circ Cardiovasc Interv. 2020 Dec;13(12):e009183. doi: 10.1161/CIRCINTERVENTIONS.120.009183. Epub 2020 Dec 4.
Results Reference
derived
PubMed Identifier
31289018
Citation
Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys PW, Okamura T, Onuma Y. Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial. EuroIntervention. 2021 Mar 19;16(16):1333-1341. doi: 10.4244/EIJ-D-18-00902.
Results Reference
derived

Learn more about this trial

Using 3D Imaging to Optimize Bifurcation Stenting

We'll reach out to this number within 24 hrs